Premier Foods plc
15 October 2004
THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR PUBLICATION,
RELEASE OR DISTRIBUTION IN OR INTO AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA, THE
UNITED STATES OR TO US PERSONS
15 October 2004
Premier Foods plc ('the Company')
The Company has today been advised by HMTF Premier Limited (an entity controlled
by funds advised by Hicks, Muse, Tate & Furst) that it has sold 49,934,781
ordinary shares of 1p each in the Company, representing approximately 20.4% of
the issued share capital via an accelerated bookbuilt offering led by Merrill
Lynch International and JPMorgan following a waiver of lock-up arrangements
undertaken at the time of the initial public offering of the Company.
Accordingly, following completion of the placing, HMTF Premier Limited will no
longer have any interest in the issued share capital of the Company.
In addition, the Company has also been advised that C.Dean Metropoulos, the
Metropoulos Five Year GRAT 2002, and Premier Management Partners, L.P. have also
collectively sold 7,334,635 ordinary shares of 1p each in the Company,
representing less than 3% of the issued share capital, in connection with the
accelerated bookbuilt offering following a waiver of their respective lock-up
arrangements. Accordingly, following completion of the placing, the
aforementioned will no longer have any interest in the issued share capital of
the Company.
The information contained herein is restricted and is not for publication,
distribution or release in or into Australia, Canada or Japan, South Africa or
the United States
This announcement is for information purposes only and does not constitute an
offer or an invitation to acquire or dispose of any securities. Neither this
announcement nor the information contained herein is an offer of securities for
sale in the United States or in any other jurisdiction . The securities referred
to herein have not been and will not be registered under the U.S. Securities Act
of 1933, as amended (the 'Securities Act') and may not be offered or sold in the
United States absent registration under the Securities Act or an applicable
exemption from registration. No public offering of the securities referred to
herein will be made in the United States, the United Kingdom or elsewhere.
Merrill Lynch International and J.P. Morgan Securities Ltd. are acting for the
selling shareholders in connection with the placing and no one else and will not
be responsible to anyone other than the selling shareholders for providing the
protections offered to its clients nor for providing advice in relation to the
above transaction. No representation or warranty, express or implied, is or will
be made as to, or in relation to, and no responsibility or liability is or will
be accepted by Merrill Lynch International or J.P. Morgan Securities Ltd. or by
any of their respective officers, servants or agents as to or in relation to the
accuracy or completeness of this release, or any other written or oral
information made available to any interested party or its advisers and any
liability therefore is hereby expressly disclaimed.
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.